Clinical trial
Occlusion Versus Pharmacologic Therapy for Moderate Amblyopia
NCT00000170 · Jaeb Center for Health Research, Other · Completed
Key facts
| NCT number | NCT00000170 |
|---|---|
| Title | Occlusion Versus Pharmacologic Therapy for Moderate Amblyopia |
| Official title | Amblyopia Treatment Study: Occlusion Versus Pharmacologic Therapy for Moderate Amblyopia |
| Lead sponsor | Jaeb Center for Health Research, Other |
| Collaborators | National Eye Institute (NEI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Amblyopia |
| Intervention type | Device, Drug |
| Interventions | Atropine, Eye Patch |
| Enrollment | 419 |
| Start date | Apr 1, 1999 |
| Primary completion | Nov 1, 2001 |
| Completion | Aug 1, 2013 |
| First posted | Sep 24, 1999 |
| Last update posted | Mar 6, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: